Hybrid deep model for predicting anti-cancer drug efficacy in colorectal cancer patients

被引:0
|
作者
Karthikeyan, A. [1 ]
Jothilakshmi, S. [1 ]
Suthir, S. [2 ]
机构
[1] Annamalai Univ, Dept Informat Technol, Chidambaram 608002, Tamil Nadu, India
[2] Amrita Vishwa Vidyapeetham, Dept Comp Sci & Engn, Amrita Sch Comp, Chennai, Tamil Nadu, India
关键词
Drug efficacy prediction; Recursive Feature Elimination with Hybrid Machine Learning mechanism; Gini impurity; Updated Rectified Linear Unit-Deep Convolutional Neural Network; Colorectal Cancer;
D O I
10.3233/WEB-230260
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Cancers are genetically diversified, so anticancer treatments have different levels of efficacy on people due to genetic differences. The main objective of this work is to predict the anticancer drug efficiency for colorectal cancer patients to reduce the mortality rates and provides immune energy for the patients. This paper proposes a novel anti-cancer drug efficacy system in colorectal cancer patients. The input data gene is normalized with the Min-Max normalization technique that normalizes the data in distinct scales. Subsequently, proposes an improved entropy-based feature to evaluate the uncertainty distribution of data, in which it induces weight to overcome the issue of computational complexity. Along with this feature, a correlation-based feature and statistical features are also retrieved. Subsequently, proposes a Recursive Feature Elimination with Hybrid Machine Learning (RFEHML) mechanism for selecting the appropriate feature set by eliminating the recursive features with the aid of hybrid Machine Learning strategies that combine decision tree and logistic regression. Also, the Gini impurity is employed for ranking the feature and selecting the maximum importance score by eliminating the least acquired importance score. Further, proposes a hybrid model for predicting the drug efficiency with the trained feature set. The hybrid model comprises of Long Short-Term Memory (LSTM) and Updated Rectified Linear Unit-Deep Convolutional Neural Network (UReLU-DCNN) model, in which DCNN is modified by updating the activation function at the fully connected layer. Consequently, the learned feature predicts the drug efficacy of anti-cancer in colorectal cancer patients by determining whether the patient is a responder or non- responder of the drug. Finally, the performance of the proposed RFEHML model is compared with other traditional approaches. It is found that the developed method has higher accuracy for each learning percentage, with values of 60LP = 92.48%, 70LP = 94.28%, 80LP = 95.24%, and 90LP = 96.86%, respectively.
引用
收藏
页码:359 / 380
页数:22
相关论文
共 50 条
  • [31] Mitosis as an anti-cancer drug target
    Salmela, Anna-Leena
    Kallio, Marko J.
    CHROMOSOMA, 2013, 122 (05) : 431 - 449
  • [32] Predicting the concentration level of an anti-cancer drug during treatment of a living organism
    Moxnes, JF
    Hausken, K
    MEDICAL HYPOTHESES, 2003, 60 (04) : 498 - 500
  • [33] Dihydroartemisinin is a hypoxia-active anti-cancer drug in colorectal carcinoma cells
    Ontikatze, Teona
    Rudner, Justine
    Handrick, Rene
    Belka, Claus
    Jendrossek, Verena
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [34] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shoyo Shibata
    Maiko Matsushita
    Yoshimasa Saito
    Takeshi Suzuki
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 442 - 448
  • [35] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shibata, Shoyo
    Matsushita, Maiko
    Saito, Yoshimasa
    Suzuki, Takeshi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (04) : 442 - 448
  • [36] The comparative anti-cancer effects of krill oil and oxaliplatin in an orthotopic mouse model of colorectal cancer
    Jayathilake, Abilasha Gayani
    Hassanzadeganroudsari, Majid
    Jovanovska, Valentina
    Luwor, Rodney Brain
    Nurgali, Kulmira
    Su, Xiao Qun
    NUTRITION & METABOLISM, 2022, 19 (01)
  • [37] The comparative anti-cancer effects of krill oil and oxaliplatin in an orthotopic mouse model of colorectal cancer
    Abilasha Gayani Jayathilake
    Majid Hassanzadeganroudsari
    Valentina Jovanovska
    Rodney Brain Luwor
    Kulmira Nurgali
    Xiao Qun Su
    Nutrition & Metabolism, 19
  • [38] Unrecognized Exposure of Anti-Cancer Drug to the Attendant Family Members of Pediatric Cancer Patients
    Koga, Yuhki
    Noda, Yuko
    Ohta, Momoe
    Ueda, Tamaki
    Ono, Hiroaki
    Oba, Utako
    Nakashima, Kentaro
    Souzaki, Ryota
    Miyazono, Mami
    Kifune, Miho
    Taguchi, Tomoaki
    Ohga, Shouichi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S18 - S18
  • [39] PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents
    Senevirathne, Suchithra A.
    Washington, Katherine E.
    Biewer, Michael C.
    Stefan, Mihaela C.
    JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (03) : 360 - 370
  • [40] shinyDeepDR: A user-friendly R Shiny app for predicting anti-cancer drug response using deep learning
    Wang, Li-Ju
    Ning, Michael
    Nayak, Tapsya
    Kasper, Michael J.
    Monga, Satdarshan P.
    Haung, Yufei
    Chen, Yidong
    Chen, Yu-Chiao
    PATTERNS, 2024, 5 (02):